Women are often underrepresented in endovascular therapy trials, leading to a lack of specific data on stent and bypass surgical outcomes for them. A recent analysis of data from the REVIVE study aimed to address this gap by focusing on the outcomes for women. The study provides valuable insights into the effectiveness and safety of these therapies for female patients. This research highlights the importance of including more women in clinical trials to ensure that medical treatments are tailored to their unique needs and characteristics.
Source link
Are the PAD Interventions for Men Safe in Women?
